Protein kinase activity of phosphoinositide 3-kinase regulates β-adrenergic receptor endocytosis

Author:  ["Sathyamangla V. Naga Prasad","Arundathi Jayatilleke","Aasakiran Madamanchi","Howard A. Rockman"]

Publication:  Nature Cell Biology

CITE.CC academic search helps you expand the influence of your papers.

Tags:  general   CellBiology   CancerResearch   DevelopmentalBiology   StemCells   Biological

Abstract

Phosphoinositide 3-kinase (PI(3)K) is a unique enzyme characterized by both lipid and protein kinase activities. Here, we demonstrate a requirement for the protein kinase activity of PI(3)K in agonist-dependent β-adrenergic receptor (βAR) internalization. Using PI(3)K mutants with either protein or lipid phosphorylation activity, we identify the cytoskeletal protein non-muscle tropomyosin as a substrate of PI(3)K, which is phosphorylated in a wortmannin-sensitive manner on residue Ser 61. A constitutively dephosphorylated (S61A) tropomyosin mutant blocks agonist-dependent βAR internalization, whereas a tropomyosin mutant that mimics constitutive phosphorylation (S61D) compliments the PI(3)K mutant, with only lipid phosphorylation activity reversing the defective βAR internalization. Notably, knocking down endogenous tropomyosin expression using siRNAs that target different regions of tropomyosin resulted in complete inhibition of βAR endocytosis, showing that non-muscle tropomyosin is essential for agonist-mediated receptor internalization. These studies demonstrate a previously unknown role for the protein phosphorylation activity of PI(3)K in βAR internalization and identify non-muscle tropomyosin as a cellular substrate for protein kinase activity of PI(3)K.

Cite this article

Naga Prasad, S., Jayatilleke, A., Madamanchi, A. et al. Protein kinase activity of phosphoinositide 3-kinase regulates β-adrenergic receptor endocytosis. Nat Cell Biol 7, 785–796 (2005). https://doi.org/10.1038/ncb1278

View full text

>> Full Text:   Protein kinase activity of phosphoinositide 3-kinase regulates β-adrenergic receptor endocytosis

Cdc2–cyclin E complexes regulate the G1/S phase transition

Telomere fusion to chromosome breaks reduces oncogenic translocations and tumour formation